We evidence that FOXO1 activity can be pharmacologically modulated to recover muscle homeostasis in ALS cells and to improve the neuromuscular function in ALS Drosophila models with muscle-specific TDP-43 and FUS silencing. Here, FUS is linked to amyotrophic lateral sclerosis.